Internal Medicine · West Long Branch, NJ
NPI
1699716175
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
232 Norwood Ave
West Long Branch, NJ, 07764
Phone (732) 222-6637
Groups this clinician bills Medicare through
Medicare paid, 2024
$265K
3,930 services
Medicare patients, 2024
654
Average age 74
Drug cost, 2024
$1.6M
15,228 prescriptions
Company payments, 2025
$1,923
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sherif Malek was code 99214 (office e&m - established), 1,134 times for 480 patients. In total Sherif Malek billed 3,930 services in 61 codes, and Medicare paid $265K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,134 | 480 | $98.15 | $111K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 433 | 433 | $136.53 | $59K |
| 93000 Electrocardiogram | Office | 332 | 320 | $9.96 | $3,308 |
| 93005 Electrocardiogram | Office | 332 | 320 | $4.56 | $1,515 |
| 93010 Electrocardiogram | Office | 332 | 320 | $5.56 | $1,845 |
| 99497 Care Management/Coordination | Office | 139 | 139 | $65.94 | $9,166 |
| 87428 Infectious Agent Detection by DNA/RNA | Office | 134 | 112 | $68.88 | $9,230 |
| 99442 Telephone Services | Office | 92 | 78 | $67.49 | $6,209 |
| 81003 Clinical Chemistry | Office | 87 | 55 | $2.17 | $189 |
| G0008 Administration of influenza virus vaccine | Office | 81 | 80 | $34.22 | $2,772 |
| 90662 Vaccine Product | Office | 81 | 81 | $79.68 | $6,454 |
| 82570 Clinical Chemistry | Office | 80 | 51 | $5.02 | $401 |
| 99212 Office E&M - Established | Office | 59 | 27 | $46.05 | $2,717 |
| G0405 Electrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination | Office | 51 | 51 | $5.70 | $291 |
| 99215 Office E&M - Established | Office | 48 | 46 | $138.20 | $6,634 |
By year: 2022 $264K for 4,036 services; 2023 $267K for 4,193 services; 2024 $265K for 3,930 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87428 Infectious Agent Detection by DNA/RNA | 134 | 112 | $68.88 | $9,230 |
| 81003 Clinical Chemistry | 87 | 55 | $2.17 | $189 |
| 82570 Clinical Chemistry | 80 | 51 | $5.02 | $401 |
Medicare prescription drug claims, 2024
In 2024, the drug Sherif Malek prescribed most often to Medicare patients was Amlodipine Besylate, with 756 prescriptions and refills. In total Sherif Malek wrote 15,228 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 756 | 1,438 | 182 | $5,356 |
| Atorvastatin Calcium Generic | 660 | 1,361 | 160 | $7,344 |
| Levothyroxine Sodium Generic | 484 | 1,050 | 109 | $4,852 |
| Pantoprazole Sodium Generic | 467 | 871 | 107 | $5,251 |
| Alprazolam Generic | 438 | 526 | 94 | $2,345 |
| Rosuvastatin Calcium Generic | 403 | 1,031 | 119 | $5,096 |
| Metoprolol Succinate Generic | 348 | 667 | 75 | $5,077 |
| Escitalopram Oxalate Generic | 324 | 571 | 65 | $3,798 |
| Losartan Potassium Generic | 324 | 726 | 78 | $3,079 |
| Gabapentin Generic | 318 | 425 | 68 | $4,677 |
| Metformin Hcl Generic | 288 | 634 | 70 | $2,239 |
| Duloxetine Hcl Generic | 211 | 289 | 30 | $3,357 |
| Trazodone Hcl Generic | 210 | 317 | 50 | $1,790 |
| Furosemide Generic | 202 | 355 | 59 | $673 |
| Zolpidem Tartrate Generic | 187 | 257 | 34 | $1,603 |
Brand drugs: 2,409 claims; generic drugs: 12,721 claims; opioid claims: 188.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sherif Malek $1,923 ($1,923 in general payments such as food, travel and fees) from 19 companies. The largest payer was Novo Nordisk Inc with $459.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 28 | $459 |
| Corcept Therapeutics CORT | 16 | $239 |
| Abbvie Inc. ABBV | 12 | $179 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $174 |
| Amgen Inc. AMGN | 13 | $162 |
| Bard Peripheral Vascular, Inc. BDX | 1 | $161 |
| Phathom Pharmaceuticals, Inc. PHAT | 7 | $97.54 |
| GlaxoSmithKline, LLC. GSK | 4 | $68.18 |
| Pfizer Inc. PFE | 3 | $58.14 |
| Lilly USA, LLC LLY | 3 | $55.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.